Clinical overview:

Non-smoker, normotensive, reports occasional chest discomfort on exertion
Cardiac CT showed a CAC score of 450
Despite treatment with atorvastatin 40 mg daily, his lipids remain elevated

Lipid profile:
Total cholesterol: 4.2 mmol/L (162 mg/dL)
Non-HDL-C: 2.9 mmol/L (112 mg/dL)
LDL-C: 2.4 mmol/L (93 mg/dL)
HDL-C: 1.3 mmol/L (50 mg/dL)
Triglycerides: 1.0 mmol/L (89 mg/dL)

Clinical overview:

Smoker for 30 years (one pack per day), diagnosed with T2DM at 45
She is normotensive, with normal renal function and a BMI of 28 kg/m²
She presents to her endocrinologist for adjustment of glucose-lowering treatment
Her HbA1c is at 7.6% and she takes metformin and liraglutide
She reports calf pain on exertion. Her ankle–brachial index is 0.55 and Doppler ultrasound demonstrates bilateral obstructive disease of femoral arteries
Despite treatment with rosuvastatin 20 mg daily, her lipids remain elevated

Lipid profile:
Total cholesterol: 4.7 mmol/L (181 mg/dL)
Non-HDL-C: 3.5 mmol/L (135 mg/dL)
LDL-C: 2.5 mmol/L (97 mg/dL)
HDL-C: 1.2 mmol/L (46 mg/dL)
Triglycerides: 2.1 mmol/L (186 mg/dL)

Clinical overview:

Smoker for 30 years (one pack per day), normotensive, reports calf pain on exertion
Her ankle–brachial index is 0.75 and Doppler ultrasound demonstrates bilateral obstructive disease of femoral arteries
Further ultrasound reveals a 60% stenosis of the left carotid artery and focal atherosclerotic plaques in the proximal abdominal aorta
Despite treatment with rosuvastatin 20 mg daily, her lipids remain elevated

Lipid profile:
Total cholesterol: 4.7 mmol/L (181 mg/dL)
Non-HDL-C: 3.5 mmol/L (135 mg/dL)
LDL-C: 2.5 mmol/L (97 mg/dL)
HDL-C: 1.2 mmol/L (46 mg/dL)
Triglycerides: 2.1 mmol/L (186 mg/dL)

Clinical overview:

Non-smoker, diagnosed with T2DM at 45
He is normotensive, with a BMI of 27 kg/m²
He presents to his endocrinologist for adjustment of glucose-lowering treatment
His HbA1c is 7.6%, he takes metformin and liraglutide
He reports occasional chest discomfort on exertion
Cardiac CT showed a CAC score of 450
Despite treatment with atorvastatin 40 mg daily, his lipids remain elevated

Lipid profile:
Total cholesterol: 4.3 mmol/L (166 mg/dL)
Non-HDL-C: 3.4 mmol/L (131 mg/dL)
LDL-C: 2.5 mmol/L (97 mg/dL)
HDL-C: 0.9 mmol/L (35 mg/dL)
Triglycerides: 2.0 mmol/L (177 mg/dL)

Clinical overview:

Smoker for 50 years, had a transient ischaemic attack three years ago
He is normotensive on an ACE inhibitor/diuretic combination; renal function not impaired
Three months ago, he suffered a STEMI and underwent successful PCI of the left circumflex artery
During hospitalisation, mixed dyslipidaemia was diagnosed and combination therapy with rosuvastatin 40 mg and ezetimibe was initiated
Despite this, his lipids remain elevated

Lipid profile:
Total cholesterol: 3.8 mmol/L (147 mg/dL)
Non-HDL-C: 2.6 mmol/L (101 mg/dL)
LDL-C: 1.9 mmol/L (73 mg/dL)
HDL-C: 1.2 mmol/L (46 mg/dL)
Triglycerides: 1.4 mmol/L (124 mg/dL)

Dyslipidaemia

Latest Articles

ODYSSEY data mining

Managing dyslipidemia in your ASCVD patients according to the new guidelines

ACS EuroPath Survey

Upcoming events

CardioRisk WebApp